Skip to main content
Clinical Trials/EUCTR2018-002176-41-GB
EUCTR2018-002176-41-GB
Active, not recruiting
Phase 1

PREvention of STroke in Intracerebral haemorrhaGE survivors with Atrial Fibrillation (PRESTIGE-AF) - PRESTIGE-AF

Imperial College London0 sites654 target enrollmentJuly 30, 2020

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Imperial College London
Enrollment
654
Status
Active, not recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 30, 2020
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Age \= 18 years
  • 2\. Written informed consent
  • 3\. Recent history of a non\-traumatic spontaneous ICH during the 6 months before enrolment
  • 4\. Documented evidence of AF (paroxysmal, persistent or permanent)
  • CHA2DS2\-VASc score\=2 for male, and CHA2DS2\-VASc score\= 3 for female patients
  • 5\. Availability of brain imaging following the index Intracerebral Haemorrhage (ICH)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 100

Exclusion Criteria

  • 1\. Patient lacks capacity to consent
  • 2\. Fully dependent (defined as a modified Rankin Scale score of over 4\)
  • 3\. Women who are pregnant, breastfeeding, or plan to become pregnant during the Study period
  • 4\. Women of childbearing potential (WOCBP) who are unable or unwilling to take measures for effective contraception
  • 5\. ICH occurring within the last 14 days before enrolment
  • 6\. ICH occurring longer than 6 months before enrolment
  • 7\. ICH resulting from trauma or vascular malformation
  • 8\. Another indication for long\-term anticoagulation
  • 9\. Patient has hypertension, which in the opinion of the investigator, is uncontrollable with medication
  • 10\. Any contraindication (except intracerebral haemorrhage) to treatment with apixaban, dabigatran, edoxaban, rivaroxaban as per SmPC. Including any of the following:

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Prevention of Stroke in Survivors of Brain Bleeding with Atrial Fibrillatio
EUCTR2018-002176-41-ATImperial College of Science, Technology and Medicine654
Active, not recruiting
Phase 1
Prevention of Stroke in Survivors of Brain Bleeding with Atrial FibrillatioIschaemic stroke prevention in patients with atrial fibrillation and previous intracerebral haemorrhageTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2018-002176-41-ESImperial College of Science, Technology and Medicine654
Active, not recruiting
Phase 1
Prevention of Stroke in intracerebral haemorrhage survivors with Atrial FibrillatioIschaemic stroke prevention in patients with atrial fibrillation and previous intracerebral haemorrhageMedDRA version: 20.0Level: LLTClassification code 10003661Term: Atrial fibrillation paroxysmalSystem Organ Class: 100000004849MedDRA version: 20.0Level: LLTClassification code 10034039Term: Paroxysmal atrial fibrillationSystem Organ Class: 100000004849MedDRA version: 20.0Level: LLTClassification code 10066551Term: Chronic atrial fibrillationSystem Organ Class: 100000004849MedDRA version: 20.0Level: LLTClassification code 10071668Term: Permanent atrial fibrillationSystem Organ Class: 100000004849MedDRA version: 22.1Level: LLTClassification code 10057613Term: Thromboembolic strokeSystem Organ Class: 100000004852MedDRA version: 21.1Level: LLTClassification code 10022754Term: Intracerebral hemorrhageSystem Organ Class: 100000004852Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2018-002176-41-DEImperial College of Science Technology and Medicine654
Active, not recruiting
Phase 1
Prevention of Stroke in Survivors of Brain Bleeding with Atrial FibrillatioIschaemic stroke prevention in patients with atrial fibrillation and previous intracerebral haemorrhageMedDRA version: 20.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 21.1Level: LLTClassification code 10067816Term: Cardioembolic strokeSystem Organ Class: 100000004852MedDRA version: 20.1Level: LLTClassification code 10055815Term: Haemorrhage intracerebralSystem Organ Class: 100000004852Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2018-002176-41-FRImperial College of Science, Technology and Medicine654
Active, not recruiting
Phase 1
Prevention of Stroke in Survivors of Brain Bleeding with Atrial Fibrillatio
EUCTR2018-002176-41-ITImperial College of Science, Technology and Medicine654